1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF93 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA ZRANB3 CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA ZSCAN12 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA ZSCAN2 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA ZSCAN23 CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA ZSCAN29 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA ZSCAN5A CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA ZSCAN5B CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ZSWIM5 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ZXDC CTRPv2 pan-cancer AAC 0.15 3e-05
Download CSV